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1. Introduction
   In recent years, there has been growing interest in 
alternative therapies and the therapeutic use of natural 
products, especially those derived from plants[1]. This 
interest in drugs of plant origin is limited due to several 
reasons, namely, conventional medicine can be inefficient 
(e.g. side effects and ineffective therapy), abusive and/or 
incorrect use of synthetic drugs results in side effects and 
other problems[2]. Large percentage of the world’s population 
does not have access to conventional pharmacological 
treatment, and folk medicine and ecological awareness 
suggests that natural products are harmless. However, the 
use of these substances is not always authorized by legal 
authorities dealing with efficacy and safety procedures, 
and many published papers explained the lack of quality 
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Objective: To evaluate the antibacterial activities of the crude leaves extracts of Zehneria scabra 
(Z. scabra) and Ricinus communis (R. communis) against Escherichia coli (E. coli), Staphylococcus 
aureus (S. aureus) and methicillin resistance S. aureus. 
Methods: The crude powdered leaves of Z. scabra and R. communis were extracted successively 
by organic solvents in increasing polarity [benzene, chloroform:acetone (1:1), 70% alcohol and 
distilled water]. The antibacterial susceptibility of the crude leaves extracts of were tested against 
standard strains of E. coli (ATCC 25922) and S. aureus (ATCC 2923) and clinical isolates of  E. coli, S. 
aureus and methicillin resistance S. aureus using agar well diffusion method. 
Results: In Z. scabra and R. communis leaf extracts, the most sensitive standard strain was S. 
aureus with an inhibition zone of (14.00依1.20) mm and (15.90依2.13) mm, respectively. The minimum 
inhibitory concentration (MIC) values of Z. scabra extracts against test organisms ranged from 1.95 
mg/mL for extract 3 in clinical and standard strains of S. aureus to 250 mg/mL for extract 1 and 4 
in clinical and standard strains of E. coli. The MIC values of R. communis extracts against test 
organisms ranged from 1.95 mg/mL for extract 2 and 3 standard strains of S. aureus to 250 mg/mL 
for extract 1 in clinical isolate of E. coli. Most of the minimum bactericidal concentration and MIC 
values of plant extracts were almost similar particularly in R. communis, or minimum bactericidal 
concentration equal to one dilution factor less than MIC value of the extracts mainly in Z. scabra. 
Conclusions: The potency of plant extracts against test organisms were depend on different 
organic solvents used. Clinical isolate of bacterial pathogens showed less zones of diameter 
compared to the standard strains. Gram-positive had wide inhibition zones than Gram-negative 
bacteria. Further studies should be carried out to isolate the pure compounds and standardization 
of the methods of plant extracts for an in vitro testing.   
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in the production, trade and prescription of phytomedicinal 
products. So, formulation of plants for standardization and 
regulation of phytomedicinal products is the most alternative 
way[3].
   In Ethiopia, medicinal plants have been used as traditional 
medicine to treat number of human and animal ailments by 
the local people from time immemorial. About 80% of the 
population in Ethiopia uses traditional medicine, mainly 
herbal plants[4]. Zehneria scabra (Z. scabra) and Ricinus 
communis (R. communis) are some of the traditionally used 
medicinal plants. Z. scabra, vernacular name is called 
“Hareg Resa” in Amharic, is a climbing or trailing herb 
belongs to the Cucurbitaceae that can go up to 10 m. Old 
stems become woody with corky-ridged bark. It inhabits 
forest and on forest margins, riverine fringes and exotic 
plantations across 900-2 100 m above sea level with a 
widespread in tropical Africa, South Africa, Arabia, India, 
Java and the Philippines[5]. In Ethiopia, Z. scabra is one 
of the traditional medical plants commonly used for the 
treatment of alopecia, wound and eczema, burn remedy and 
skin rashes as part of a poly-herbal preparation, the ash 
and wash prepared from pounded leaves[6]. R. communis 
popularly called castor bean in English and Gulo in 
Amharic. It is widely spread as a wild plant through East 
and North Africa. In Ethiopia, castor plant is important to 
treat tooth ache, cold, dysentery and itachy, fetal membrane 
retention and rabies in different preparation[7-9]. 
   Ethno-botanical studies revealed that Z. scabra and R. 
communis are being used in the treatment of pathogenic 
organisms in the traditional health care system in Ethiopia. 
However, very little work has been done to evaluate their 
efficacy in scientific way[10]. Therefore, this study was 
aimed to evaluate the in vitro antibacterial activity of crude 
leaf extractions of Z. scabra and R. communis against 
standard and clinical isolates of Escherichia coli (E. coli), 
Staphylococcus aureus (S. aureus) including methicillin 
resistance S. aureus (MRSA). 
2. Materials and methods
2.1. Study area 
   The study was conducted at University of Gondar, Gondar 
town. It is located in the North West Ethiopia of Amhara 
region. The town has an elevation of 2 080 m above sea 
level with a mid-altitude climate and an average annual 
maximum temperature of 30 °C and minimum temperature of 
16 °C[11].  
2.2. Plant material
2.2.1. Sampling, sample collection and identification
   Through random sampling, healthy and disease free of 
the leaves of a wild growing Z. scabra and R. communis 
were collected from gardens in Gondar town by scissors and 
samples were kept in plastic bags. The plants were identified 
and confirmed using standard manuals by plant taxonomist.
2.2.2. Preparation of crude extract
   The leaves of Z. scabra and R. communis were transported 
to Microbiology Laboratory, Department of Biology, Faculty 
of Natural and Computational Sciences, University of 
Gondar. The plant materials were washed using distilled 
water and air dried at room temperature under shade for 
10 d and powdered using wooden-made pestle and mortar. 
The powdered materials were sieved and stored in air tight 
container until use. 
   A 100 g of air-dried plant powdered leaves were measured 
by electronic balance (CY510) and then placed in a 2 000 mL 
clean round bottomed flask at room temperature caped with 
aluminum foil. After that, 1 000 mL benzene was added to the 
flask which contained powdered leaves material [1 part test 
material and 10 parts of solvent (w/v)]. The mixture was kept 
on a rotary shaker at 200 r/min for 24 h. The macerate was 
first filtered through double layer muslin cloth then through 
Whatman No. 1 filter paper and it was assigned as extract 
1. The residue was taken again and mixed with chloroform/ 
acetone with ratio 1:1 in a volume of 1 000 mL, and the filtrate 
was assigned as extract 2. The same procedure was followed 
using 70% alcohol and distilled water to obtain extract 3 and 
extract 4, respectively. These successive cold maceration 
methods were done with increasing order of their polarity[13]. 
The filtrates were allowed to concentrate under rotary vapor 
(RE 2000) at 40 °C, weighed and stored in sterilized air tight 
container at 4 °C for further analysis.
2.3. Test organisms
   Standard strains of E. coli (ATCC 25922) and S. aureus 
(ATCC 2923) were collected from Biomedical and Laboratory 
Sciences Research Center, University of Gondar while 
clinical isolates of E. coli, MRSA and S. aureus were collected 
from Ethiopian Health and Nutrition Research Institute, 
Addis Ababa. The microorganisms were transported to 
Microbiology Laboratory by using nutrient agar slant and 
preserved at 4 °C for further use.
2.4. Standard antibiotics
   Ciprofloxacin (in the form of powder) having a broad 
spectrum property was used as a positive control (5 µg/mL).
2.5. Inocula preparation
   The inocula preparation was carried out by growth 
methods[14,15]. The test organisms from nutrient agar slant 
were transferred into a nutrient agar medium to get a pure 
colony at 37 °C for 24 h. Three to five pure colonies were 
selected and transferred into a sterile test tube containing 
5 mL of sterile nutrient broth and the solutions were mixed 
by a vortex mixer. The broth culture was incubated at 37 °C 
until it reached the turbidity of (105-106 CFU/mL) which was 
equivalent to 0.5 McFarland standards (usually about 8 h) 
and turbidity was adjusted visually by comparing the test. 
2.6. Agar well diffusion method
   Susceptibility tests were performed by agar well diffusion 
method using Muller-Hinton agar[16,17]. A sterile cotton 
swabs were dipped into the adjusted suspension by pressing 
and rotating the swabs firmly against the inside of the tube 
above the fluid level. The swab was then evenly streaked 
over the entire surface of the Muller-Hinton agar plate 
repeatedly by rotating the plate approximately 600 each 
time and the rim of the agar was swabbed to obtain uniform 
inoculums. On each plate, six equidistant wells (one in the 
center and five wells at the corner) were made with a 6 mm 
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diameter sterilized cork borer, 2 mm from the edge of the 
plate[15].
   Five of the holes were aseptically filled with 50 µL of 
different concentrations of each plant extracts (i.e. 100 mg/
mL, 200 mg/mL, 300 mg/mL, 400 mg/mL and 500 mg/mL) 
sequentially, and at the center, ciprofloxacin was added as a 
positive control. The amount of control was the same as the 
tested sample on the wells. Petri plates were placed at 4 °C 
for 2 h to allow diffusion of the extract into the agar and then 
incubated at (37依0.1) °C for 24 h. At the end the inhibition 
zones formed were measured to the nearest millimeters and 
the experiment was performed in duplicate. Experiments 
that gave contradicting results were done for the third time 
for an easy decision.
2.7. Determination of minimum inhibitory concentration 
(MIC)
   MIC of crude extracts of the Z. scabra and R. communis 
were performed using two fold broth dilution methods[18]. 
The extract solution (500 mg/mL) was serially diluted with 
nutrient broth as 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128 and 1:256 
to bring 250 mg/mL, 125 mg/mL, 62.5 mg/mL, 31.25 mg/
mL, 15.63 mg/mL, 7.81 mg/mL, 3.95 mg/mL and 1.95 mg/
mL concentrations, respectively and 20 µL of a standard 
suspension of the test organism was added to each 
concentration of the extract. Two test tubes containing 
nutrient broth without antimicrobial agent were added in 
each test. One of these tubes was inoculated with the test 
organism; the other was left uninoculated and served as a 
control for media sterility. The broth plates were incubated 
at 37 °C for 24 h. The lowest concentration, at which there 
was no turbidity, was regarded as MIC value of the extract.
2.8. Determination of minimum bactericidal concentration 
(MBC)
   MBC is the lowest concentration of an antibiotic required 
to kill a microorganism[18]. The MBC were determined by 
sub-culturing 20 µL of the test dilutions from MIC tubes on 
to fresh nutrient agar plates incubating at 37 °C for 24 h. The 
lowest concentration that killed the entire bacterial colony 
on the plates was recorded as MBC.
2.9. Statistical analysis
   One-way analysis of variance (ANOVA) was used for 
determination of the antimicrobial susceptibility test of 
phyto-chemical extracted by different solvents in the 
specific concentration. Values were expressed as mean
依SEM by using SPSS version 16 software and presented as 
tables. P values less than 0.05 were taken as statistically 
significant[19]. 
3. Results
3.1. Agar well diffusion assay of the crude leaf extracts of Z. 
scabra and R. communis
   
   Among the standard test strains, S. aureus (ATCC 2923) was 
the most susceptible bacteria [(14.00依2.00) mm], followed 
by E. coli (ATCC 25922) [(6.85依0.91) mm] to the extracts of Z. 
scabra. Among clinical isolates most susceptible strains for 
extracts of Z. scabra was S. aureus [(9.95依1.79) mm] followed 
by MRSA [(7.80依1.24) mm] and E. coli [(3.50依0.97) mm]. 
Similarly, the most susceptible standard strains for extracts 
of R. communis was S. aureus (ATCC 2923) [(15.90依2.13) mm], 
followed by E. coli (ATCC 25922) [(15.20依1.53) mm] and clinical 
isolates of S. aureus [(9.90依1.98) mm], MRSA [(9.50依2.12) mm] 
and E. coli [(7.75依0.91) mm] (Table 1).  
Table 1
Zone of inhibition against test organisms of leaf extract fractions of Z. scabra 
and R. communis.
leave type Organisms
Diameter of zone of inhibition (mm)
IZE Ciprofloxacin
Z. scabra E. coli* 3.50依0.97 26.75依0.33
E. coli** 6.85依0.91 31.25依0.19
MRSA 7.80依1.24 21.00依0.32
S. aureus* 9.95依1.79 22.00依0.22
S. aureus**           14.00依2.00 28.00依0.49
R. communis E. coli* 7.75依0.91 28.00依0.16




S. aureus* 9.90依1.98 24.00依0.49
S. aureus**           15.90依2.13 28.25依0.50
Data are expressed as mean依SEM. *: Clinical isolates; **: Standard strains; 
IZE: Inhibition zone of extract; MRSA: Methicillin resistant S. aureus.
3.2. The MIC values of Z. scabra and R. communis extracts 
against test organisms
   The MIC value of plant extracts of Z. scabra against the 
test bacteria ranged from 1.95 mg/mL (extract 3 for both 
clinical and standard stains of S. aureus) to 250.00 mg/mL 
(extract 1 and extract 4 for both clinical and standard strains 
of E. coli), respectively, (Table 2). The MIC values of extract 
3 ranged from 1.95 mg/mL to 62.5 mg/mL with the least MIC 
values compared to other crude leaf extract fraction. Extract 
4 had MIC values ranged from 15.62 mg/mL (on standard 
strains of S. aureus) to 250.00 mg/mL (on standard strains of 
E. coli) where as MIC values were negligible to other strains 
(particularly on clinical isolates). The overall trend showed 
that the MIC values of Gram-positive bacteria were lower 
than Gram-negative bacteria (Table 2).
Table 2
The MIC values of Z. scabra leaf extract fractions against test organisms using 
two fold broth dilution methods.
Organisms
Plant extracts (mg/mL)
Extract 1 Extract 2 Extract 3 Extract 4
E. coli* 250.00 62.50 62.50  -
E. coli** 125.00 31.25 31.25 250.00
MRSA
*   62.50 15.62   7.81   -
S. aureus*   15.62   3.91   1.95   31.25
S. aureus**     3.91   1.95   1.95   15.62
*: Clinical isolates; **: Standard strains; -: No MIC value.
   As indicted from Table 3, R. communis leaf extract showed 
MIC value ranging from 1.95 mg/mL to 250.00 mg/mL. The 
most effective extract that inhibited the growth of bacteria 
was extract 3 with value ranged from 1.95 mg/mL to 62.5 mg/
mL. Extract 4 inhibited all standard strains in low MIC values 
ranged from 3.91 mg/mL (S. aureus (ATCC 2923) to 7.81 mg/
mL (E. coli (ATCC 25922). Standard strain of S. aureus (ATCC 
2923) was the most sensitive with MIC value of 1.95 mg/mL to 
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extracts 2 and 3 followed by standard strain of E. coli (ATCC 
25922) and clinical isolate of S. aureus (1.95 mg/mL) to extract 
3. The most resistant bacteria were clinical isolate of E. coli 
(62.5 mg/mL) at extract 2 and 3 followed by clinical isolate of 
E. coli (250.00 mg/mL) at extract 1 (Table 3).
Table 3
The MIC values of R. communis leaf extract fractions against test organisms 
using two fold dilution methods.
Organisms
Plant extracts (mg/mL)
Extract 1 Extract 2 Extract 3 Extract 4
E. coli* 250.00 62.50 62.50  -
E. coli**     7.81   3.91   1.95   7.81
MRSA
*   62.50 15.62   7.81  -
S. aureus*   62.50   3.91   1.95 31.25
S. aureus**     3.91   1.95   1.95   3.91
*: Clinical isolates; **: Standard strains; -: No MIC value.
3.3. The MBC values of Z. scabra and R. communis extracts 
against test organisms
   MBC value of fraction 3 from leaf extract of Z. scabra was 
ranged from 1.95 mg/mL against clinical and standard strains 
of S. aureus to 62.5 mg/mL against clinical isolate of E. coli. 
The second important extract in Z. scabra leaf was extract 
2 ranged from 3.91 mg/mL against standard strain S. aureus 
to 62.5 mg/mL against clinical isolate of E. coli followed by 
extract 1 that ranged from 7.81 mg/mL against standard strain 
S. aureus to 500.00 mg/mL against clinical isolate of E. coli 
(Table 4).
Table 4
The MBC of Z. scabra leaf extract fractions against test organisms.
Organisms
Plant extracts (mg/mL)
Extract 1 Extract 2 Extract 3 Extract 4
E. coli* 500.00 62.50 62.50   -
E. coli** 250.00 31.25 31.25 250.00
MRSA
*   62.50 15.62   7.81   -
S. aureus*   15.62   7.81   1.95   31.25
S. aureus**     7.81   3.91   1.95   15.63
*: Clinical isolates; **: Standard strains; -: No MBC values.
   R. communis leaf extract fraction showed greater effects 
in inhibiting bacterial growth in this study, with MBC values 
ranged from 1.91 mg/mL of extract 3 against standard and 
clinical isolates of S. aureus to 250 mg/mL of extract 1 against 
clinical isolate strains of E. coli. Standard strain of E. coli 
was the most sensitive strains next to S. aureus (3.91 mg/mL 
from extract 3) (Table 5).
Table 5
The MBC of R. communis leaf extract fraction against test organisms.
Organisms
Plant extracts (mg/mL)
Extract 1 Extract 2 Extract 3 Extract 4
E. coli* 250.00 125.00 62.50   -
E. coli**   15.62    7.81   3.91  15.62
MRSA
*   62.50  15.62   7.81 -
S. aureus*   62.50    7.81   1.95 125.00
S. aureus*   31.25    1.95   1.95  62.50
*: Clinical isolates; **: Standard strains; -: No MBC values.
4. Discussion
   In this study, leaf extracts of Z. scabra showed maximum 
zone of inhibition (14.00依2.00) mm against standard strain 
of S. aureus (ATCC 2923) followed by (9.95依1.79) mm against 
clinical isolate of S. aureus. The least diameter of zone of 
inhibition recorded was (3.50依0.97) mm against clinical 
isolate of E. coli. Similarly, other study conducted by Anand 
et al. indicated that ethanol, methanol, ethyl acetate and 
aqueous extracts of the shoot of Z. scabra from the standard 
bacterial pathogen of S. aureus showed maximum zone of 
inhibition (50.00依0.11) mm[20], while in a study conducted by 
Bruck[21], methanol leaves extracts of Z. scabra had no effect 
on the tested microbes except at higher concentration low 
activity against standard strain of S. aureus (6 mm). These 
variations in zone of inhibitions may be due to the difference 
in concentration of active pricnciple; type of solvent used for 
extraction and type of bacterial strains tested[20].  
   Crude leaves extracts of R. communis demonstrated 
maximum zone of inhibition against standard strains of 
S. aureus (ATCC 2923) was (15.90依2.13) mm, followed by E. 
coli (ATCC 25922) [(15.20依1.53) mm], clinical isolates of S. 
aureus [(9.90依1.98) mm] and MRSA [(9.50依2.12) mm]. The least 
inhibition zone was recorded from clinical isolate of E. coli 
(7.75依0.91) mm. A similar study conducted by Kensa and 
Yasmin showed that the most sensitive strain was E. coli 
(11.3 mm)[22]. While other reports by Chukwuka et al. showed 
that R. communis leaf extract did not inhibit E. coli[23]. The 
difference might be related to many factors such as age of 
the plant, plant part used, solvent concentration, tested 
strains used and extraction procedures followed[21]. 
   The results of the present study showed that standard 
bacterial strain of S. aureus was the most susceptible 
bacterium, which may be attributed to the absence of outer 
membrane of the organism that makes it more accessible 
to permeation by active principles of the leaves extracts of 
Z. scabra and R. communis[18]. Promising inhibition zone 
was also obtained against MRSA which shows that herbal 
preparations are important alternatives for drug resistant 
bacteria pathogens. Crude leaves extracts of Z. scabra and R. 
communis have shown an interesting profile of antibacterial 
activity against standard bacterial strains more than clinical 
isolates and Gram-positive strains are more sensitive to the 
extracts. Therefore, further study is needed to isolate the 
pure compounds from these crude extracts.
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   In developing countries, about 80% of the population uses 
medicinal plants as traditional medicine to treat infectious 
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diseases. Z. scabra and R. communis are being used for 
treatment of pathogenic organisms in the traditional health 
care system. This study aimed to evaluate antibacterial 
activity of crude extract from Z. scabra and R. communis 
against clinical and standard strains.  
  
Research frontiers
   In this study, leaf extracts of Z. scabra and R. communis 
showed maximum zone of inhibition against standard strain 
of S. aureus. Promising inhibition zone were also obtained 
against MRSA which shows that medicinal plant extracts are 
important alternatives for drug resistant bacterial pathogens. 
Crude leaves extracts of Z. scabra and R. communis have 
shown an interesting profile of antibacterial activity against 
standard bacterial strains more than clinical isolates. Gram-
positive were more sensitive than Gram-negative strains. 
Related reports
   The antimicrobial effect of plant extracts against test 
organisms were depend on different solvents used. Similar 
study reported by Anand et al., 2012 indicated that ethanol, 
methanol, ethyl acetate and aqueous extracts of the shoot of 
Z. scabra showed maximum zone of inhibition for standard 
strains of S. aureus.
Innovations and breakthroughs
   Promising inhibition zone were obtained against S. aureus 
and MRSA which shows that medicinal plant extracts from Z. 
scabra and R. communis are important alternatives for drug 
resistant bacterial pathogens.
Applications
   In recent years, there has been growing interest in 
alternative therapies and the therapeutic use of natural 
products, especially those derived from plants. Z. scabra 
and R. communis have antimicrobial components, therefore 
looking for its formulation and components of the extract 
may lead to the production of important antibiotic alternative 
for the treatment of infectious diseases.
Peer review
   This paper is very interesting and has wide application 
in biotechnology where many researchers can follow 
the screening and extraction of natural products for the 
discovery of noble compounds. Therefore, this study is 
helpful to initiate other researchers in the area of interest.
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